Select a calendar:
Filter February Events by Event Type:
Conferences, Lectures, & Seminars
Events for February
-
BME 533 (Seminar in Biomedical Engineering)
Mon, Feb 06, 2012 @ 12:30 PM - 01:50 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: Dr. Radha Kalluri, House Ear Institute
Talk Title: CANCELLED
Abstract: CANCELLED
Host: BME Department
Location: Olin Hall of Engineering (OHE) - 122
Audiences: Everyone Is Invited
Contact: Mischalgrace Diasanta
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
Grodins Keynote Lecture
Thu, Feb 09, 2012 @ 11:00 AM - 12:00 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: Dr. Savio L-Y. Woo, Distinguished University Professor, University of Pittsburgh, Pennsylvania
Talk Title: Bioengineering: The Bridge Between Biology and Orthopaedic Surgery
Abstract: Bioengineering has made many significant contributions to clinical medicine, notably diagnostics, drug delivery and tissue repairs and replacement. Coupled with the explosive growth in biological sciences, new doors have been opened for bioengineers to introduce a new paradigm, termed Functional Tissue Engineering (FTE) for medical and surgical practices. As a result, it has become an even more attractive discipline.
In this lecture, we will discuss how bioengineering has served as the bridge between biology and clinical management of ligament and tendon injuries in orthopaedic sports medicine. Examples of how laboratory studies have contributed to both non-operative and operative management of complete tears of ligaments and tendons will be given. In recent years, FTE, especially bioscaffolds have been used to further improve the quality of healing tendons and ligaments. Through robotics technology, new knowledge on the multiple degree-of-freedom (DOF) knee kinematics was used to improve ligament reconstruction procedures. Further, in-vivo studies of joint kinematics using novel biplanar fluoroscopy have produced valuable data on in vivo ligament and tendon function to help to develop improved treatment procedures and injury prevention strategies.
The biological complexity will continue to introduce larger gaps between diagnostics and treatment. This will present challenges as well as opportunities for bioengineers to develop new analytical and experimental techniques at the molecular, cellular, tissue and organ levels. Working in concert with biologists, clinicians, and others, it is possible to come up with more creative and scientifically based procedures to provide better patient care.
Biography: Dr. Savio L-Y. Woo is a Distinguished University Professor of Bioengineering and the Founder and Director of the Musculoskeletal Research Center (MSRC), a diverse multidisciplinary research and educational center in the Department of Bioengineering, Swanson School of Engineering at the University of Pittsburgh. He arrived at the University of Pittsburgh in 1990 after spending 20 years at the University of California, San Diego (UCSD) as a Professor of Surgery and Bioengineering.
Dr. Woo received his B.S. degree from Chico State College (1965), and M.S. and Ph.D. degrees (1966, 1971) from University of Washington. In 1999, Dr. Woo was bestowed a Doctor of Science Degree (Hon.) from the Trustees of the California State University System and in 2008, he earned a Doctor of Engineering Degree (Hon.) from The Hong Kong Polytechnic University.
Dr. Woo is a pioneer in bioengineering and is renowned for his 40 years of translational research in healing and repair of tissues. Together with his team, they have authored 315 original research papers in refereed journals as well as 141 book chapters and review articles. Their work has significantly impacted the management of ligament and tendon injuries including clinical paradigm shifts that have led to improved patient outcome.
More recently, Dr. Woo has focused on using novel functional tissue engineering to heal and to regenerate ligament and tendon at the molecular, cellular, tissue and organ levels. Also, he has pioneered the use of robotic technology to study the function of ACL and to improve ACL reconstruction procedures. When combining it with biplanar fluoroscopy, he and his team will be able to better characterize mechanisms of ACL injury and find better ways for its prevention.
Dr. Woo has educated over 465 orthopaedic surgeons, post-doctoral fellows and students from all around the globe including, Japan, Germany, Greece, Italy, Taiwan, Turkey, Korea, Canada, England, Norway, India, Thailand, Hong Kong SAR, and China. He has also mentored 37 junior faculty members.
Dr. Woo has been a leader in Bioengineering and Orthopaedics. He has served as Chair of ASMEâs Bioengineering Division, United States National Committee of Biomechanics, and the World Council for Biomechanics as well as President for The Orthopaedic Research Society, American Society of Biomechanics, and International Society for Fracture Repair. He has also founded the International Symposium on Ligaments and Tendons (ISL&T) and World Association for Chinese Biomedical Engineers (WACBE).
Dr. Woo has been inducted into the Institute of Medicine, the National Academy of Engineering, and the Academia Sinica, only one of four persons who have gained all three of these honors.
He has also received the highest honors from many professional societies, including the Kappa Delta Award, the Herbert R. Lissner Medal, the OâDonoghue Sports Injury Research Award, the Giovanni Borelli Award, and the Muybridge Medal, among others. Most recently, he was given the prestigious Diamond Award for Distinguish Achievement from the University of Washington. In 1998, Dr. Woo received the Olympic Prize for Sports Science from the International Olympic Committee and the first Olympic gold medal at the Nagano Games in Japan.
Host: Department of Biomedical Engineering
More Info: http://viterbi.usc.edu/news/events/keynote/grodins/Location: Board Room (2nd floor)
Audiences: Everyone Is Invited
Contact: Mischalgrace Diasanta
Event Link: http://viterbi.usc.edu/news/events/keynote/grodins/
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
BME 533 (Seminar in Biomedical Engineering)
Mon, Feb 13, 2012 @ 12:30 PM - 01:50 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: Daniel Kamei, Ph.D., UCLA
Talk Title: Cell traffic control: Applications in cancer drug delivery
Host: BME Department
Location: Olin Hall of Engineering (OHE) - 122
Audiences: Everyone Is Invited
Contact: Mischalgrace Diasanta
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
BME 533 (Seminar in Biomedical Engineering)
Mon, Feb 20, 2012 @ 12:30 PM - 01:50 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: NO CLASS-PRESIDENT'S DAY, NO CLASS-PRESIDENT'S DAY
Talk Title: NO CLASS-PRESIDENT'S DAY
Host: BME Department
Location: Olin Hall of Engineering (OHE) - 122
Audiences: Everyone Is Invited
Contact: Mischalgrace Diasanta
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
USC PSOC Monthly Seminar Series
Fri, Feb 24, 2012 @ 11:45 AM - 01:00 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: Andreas Matouschek, Ph.D., Northwestern University
Talk Title: How the Proteasome Picks its Substrates for Degradation
Abstract: The proteasome controls the concentrations of most proteins in the cytosol and nucleus of eukaryotic cells. The degradation signal or degron that targets proteins for proteolysis has two components, a proteasome binding tag, usually a poly-ubiquitin chain, and an initiation site in the form of an unstructured region in the substrate. The two degron components can function in trans when separated onto two different polypeptide chains so that a ubiquitinated adaptor can target a binding partner for proteolysis. Surprisingly, the initiation region contributes significantly to the specificity of Ubiquitin-Proteasome System. The length, location and amino acid sequence of initiation sites all affect whether a protein can be degraded or not. We define these rules in model systems and show how they apply to natural proteins. Once degradation has initiated, the proteasome normally digests its substrates processively to avoid the formation of fragments with undesirable activities. Interestingly, there are a few instances where this processivity breaks down and the proteasome generates partially degraded proteins. The partial degradation is caused by stop signals in the substrate proteins and we propose that this mechanism can explain steps in some signaling pathways and may involved in some neurodegenerative diseases.
Biography: Andreas Matouschek is a biologist at Northwestern University, where he is professor of biochemistry, molecular biology, and cell biology in the Weinberg College of Arts and Sciences. His graduate work with Alan Fersht resulted in the seminal application of phi-value analysis to the study of barnase, a bacterial RNAse used in many protein folding studies.Development of phi value analysis in combination with extensive protein engineering enabled an understanding of the kinetic intermediates during protein folding of barnase. In subsequent postdoctoral work at the University of Basel, he applied the protein engineering approach to studying unfolding of proteins as they pass through mitochondrial translocons.
Matouschek currently studies the proteasome, the degradation machinery of eukaryotic cells, and the mechanisms by which the proteasome is able to unfold and translocate proteins.
Host: USC Physical Sciences in Oncology Center
Location: CSC Harkness Auditorium #250
Audiences: Everyone Is Invited
Contact: Yvonne Suarez
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor. -
BME 533 (Seminar in Biomedical Engineering)
Mon, Feb 27, 2012 @ 12:30 PM - 01:50 PM
Alfred E. Mann Department of Biomedical Engineering
Conferences, Lectures, & Seminars
Speaker: Cheng-Ming Chuong, M.D., Ph.D., USC Keck School of Medicine, Dept. of Pathology
Talk Title: Opportunities for bio-engineering analyses of feathers
Host: BME Department
Location: Olin Hall of Engineering (OHE) - 122
Audiences: Everyone Is Invited
Contact: Mischalgrace Diasanta
This event is open to all eligible individuals. USC Viterbi operates all of its activities consistent with the University's Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor.
